Pharma Block Sciences: Announcement regarding the debt-for-equity swaps in the second quarter of 2024 for convertible bonds.
Pharma Block Sciences: Announcement on the Appointment of Executive Vice President of the Company.
Pharma Block Sciences: In 2022, Pharma Block Sciences Co., Ltd. in Nanjing issued convertible corporate bonds to unspecified parties on the Growth board. Follow-up rating report for 2024.
Pharma Block Sciences: Announcement on the Progress of Providing Guarantees to Wholly-owned Subsidiaries.
Pharma Block Sciences: Announcement Regarding the Resumption of Stock Conversion for Yaoshi Convertible Bonds.
Pharma Block Sciences: Pharma Block Sciences issued a report on entrusted management of convertible corporate bonds to unspecified parties (2023).
Pharma Block Sciences: Announcement regarding the debt-for-equity swaps conversion price adjustment for the 2023 annual equity distribution of convertible bonds.
Pharma Block Sciences: Notice on the Suspension of Convertible Bonds Conversion into Stocks During the Equity Distribution Period of Yao Shi.
Pharma Block Sciences: Announcement on the signing of agreements such as “Share Repurchase” and the progress of related transactions
Pharma Block Sciences: Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders
Pharma Block Sciences: Legal Opinion of the 2024 First Extraordinary General Meeting of Shareholders of Yakshi Technology
Pharma Block Sciences: Announcement on the downward revision of the conversion price of convertible corporate bonds
Pharma Block Sciences: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Pharma Block Sciences: Legal Opinion of Yakushi Technology's 2023 Annual General Meeting of Shareholders
Pharma Block Sciences: Notice on holding the 2024 First Extraordinary General Meeting of Shareholders
Pharma Block Sciences: Announcement on the board of directors proposing to revise the conversion price of convertible corporate bonds downward
Pharma Block Sciences: An indicative announcement that Yakushi's bond conversion may trigger a downward revision of the conversion price conditions
Pharma Block Sciences: Notice on opening a special settlement account for cash management
Yakushi Technology: Notice on requesting the shareholders' meeting to authorize the board of directors to issue shares to specific targets through simple procedures
Yakushi Technology: Notice on Convening the Company's 2023 Annual General Meeting of Shareholders
No Data